Clinical Pharmacology Details


SIMVASTATIN


View Drug Forms

Indications & Dose:

Primary hypercholesterolaemia, or combined(mixed) hyperlipidaemia in patients who have not responded adequately to diet and other appropriate measures



Adult: 10–20 mg once daily, then increased if necessary up to 80 mg once daily, adjusted at intervals of at least 4 weeks, dose to be taken at night; 80 mg dose only for those with severe hypercholesterolaemia and at high risk of cardiovascular complications


Homozygous familial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate measures



Adult: Initially 40 mg once daily, then increased if necessary up to 80 mg once daily, adjusted at intervals of at least 4 weeks, dose to be taken at night; 80 mg dose only for those with severe hypercholesterolaemia and at high risk of cardiovascular complications


Prevention of cardiovascular events in patients with atherosclerotic cardiovascular disease or diabetes mellitus


% BY MOUTH


Adult: Initially 20–40 mg once daily, increased if necessary up to 80 mg once daily, adjusted at intervals of at least 4 weeks, dose to be taken at night; 80 mg dose only for those with severe hypercholesterolaemia and at high risk of cardiovascular complications


DOSE ADJUSTMENTS DUE TO INTERACTIONS


Max. 10 mg daily with concomitant bezafibrate or ciprofibrate. Max. 20 mg daily with concomitant amiodarone, verapamil, diltiazem, amlodipine, or ranolazine. Max. 40 mg daily with concomitant lomitapide.

Contraindications:

Active liver disease, Pregnancy & breast feeding

Side Effects:

CNS: Dizziness, headache, insomnia, memory loss, peripheral neuropathy, tremor, vertigo


GI: Abdominal pain, constipation, diarrhea, dyspepsia, flatus, heartburn, liver dysfunction, nausea, pancreatitis, vomiting


GU: Erectile dysfunction, gynecomastia, loss of libido


HEME: Eosinophilia, hemolytic anemia, leukopenia, thrombocytopenia


MS: Muscle cramps, myalgia, myositis, rhabdomyolysis


SKIN: Alopecia, pruritus, rash, Stevens-Jhonson syndrome


 

Cautions:

Precautions:

Past liver disease, alcoholism, severe acute infections, trauma, hypotension, uncontrolled seizure disorders, severe metabolic disorders, electrolyte imbalances

Interaction:

Drugs 


Azole antifungals (fluconazole, itraconazole, ketoconazole, miconazole): Increased simvastatin levels via inhibition of metabolism with increased risk of rhabdomyolysis


Cbolestyramine, colestipol: Reduced bioBrands Available with Cost of simvastatin


Cyclosporine: Concomitant administration increases risk of severe myopathy or rhabdomyolysis


Danazol: Inhibition of metabolism (CYP3A4) fight to yield increased simvastatin levels with increased risk of rhabdomyolysis


Fluoxetine: Inhibits CYP3A4 hepatic metabolism with risk of rhabdomyolysis


Gemfibrozil: Small increased risk of myopathy with combination, especially at high doses of statin


Isradipine: Isradipine probably decreases simvastatin (like lovastatin) plasma concentrations minimally


Macrolide antibiotics (clarithromycin, erythromycin, troleandomycin): Increased simvastatin levels via inhibition of metabolism with increased risk of rhabdomyolysis


Nefazodone: Inhibit CYP3A4 hepatic metabolism (like lovastatin) with risk of rhabdomyolysis


Niacin: Concomitant administration increases risk of severe myopathy or rhabdomyolysis


Warfarin: Addition of simvastalin may increase hypoprothrombinemic response to warfarin via inhibition of metabolism (CYP2C9)


 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: